Search alternatives:
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
μ decrease » _ decreased (Expand Search), _ decreases (Expand Search), a decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
50 μ » 10 μ (Expand Search), 5 μ (Expand Search)
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
μ decrease » _ decreased (Expand Search), _ decreases (Expand Search), a decreased (Expand Search)
_ decrease » _ decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
50 μ » 10 μ (Expand Search), 5 μ (Expand Search)
-
1
-
2
Decreased Aβ42 halo overlaps with the decreased incidence of DNs in FO treated mice.
Published 2019“…<p>(A-D) Double staining of untreated 5xFAD mice brain sections with the 4g8 and SMI31 antibodies revealed that the areas with higher incidence of DNs display the greater total Aβ halo around the plaques (AmyloGlo+). …”
-
3
-
4
TITAN decreaser diatom heatmap.
Published 2025“…., <i>z-</i>) diatom taxa (y-axis) to at least one of the five stressors, in decreasing order of number of stressor responses. …”
-
5
-
6
-
7
-
8
mGluR5 receptor decreased glycinergic currents.
Published 2019“…(<b>E</b>) The inhibitory effect of CHPG on GlyR-IPSCs was not blocked by intracellularly loaded GDP-β-S (62.3 ± 6.4% of baseline at 15–20 min post-CHPG, <i>t</i>[6] = 2.782, <i>p</i> = 0.032), chelerythrine (60.9 ± 11.3% of baseline at 15–20 min post-CHPG, <i>t</i>[6] = 2.705, <i>p</i> = 0.035), or Ro-32-0432 (69.9 ± 3.2% of baseline at 15–20 min post-CHPG, <i>t</i>[5] = 8.495, <i>p</i> < 0.001). (<b>F</b>) Postsynaptic loading of U-0126 or PD98059 prevented CHPG from decreasing glycinergic responses (U-0126, 107.6 ± 10.4% of baseline at 15–20 min post-CHPG, <i>t</i>[8] = 0.997, <i>p</i> = 0.348; PD98059, 93.1 ± 5.0% of baseline at 15–20 min post-CHPG, <i>t</i>[5] = 0.883, <i>p</i> = 0.418). …”
-
9
-
10
GSK343 decreased tumor stemness.
Published 2021“…(C) COA6 cells were treated with GSK343 (0, 5 μM) for 72 hours. qPCR demonstrated a significant decrease in mRNA abundance of known stemness markers Oct4, Nanog, and Sox2 following GSK343 treatment compared to untreated cells. …”
-
11
-
12
24 hours of ARD results in noticeable decrease in ORO staining.
Published 2022“…<p>(A) Decrease in ORO signal were observable at 24 hr after worms were placed on ARD plates (as compared to control fed worms in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0274076#pone.0274076.g005" target="_blank">Fig 5</a>), as shown with representative strains. …”
-
13
-
14
-
15
FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma.
Published 2019“…<p>(A) HuH6 cells (2.5 x 10<sup>6</sup> cells in 25% Matrigel) were injected subcutaneously into the right flank of 6-week-old female athymic nude mice. …”
-
16
ABT199 inhibits ALK <sup>mutant</sup> kinase activity and decreases it phosphorylation.
Published 2025Subjects: -
17
-
18
-
19
FTY720 decreased viability, proliferation, and motility and induced apoptosis in human hepatoblastoma cells.
Published 2019“…(B) Following 24 hours of treatment with FTY720, the proliferation of HuH6 cells measured using the CellTiter 96 cell proliferation assay was significantly decreased (IC<sub>50</sub> = 6.4 μM, p ≤ 0.05). (C) HuH6 cells were plated and allowed to reach 80% confluence, at which time the media was changed for fresh media (0, 5, or 8 μM FTY720) and a standard scratch wound was made. …”
-
20